A key mission of the Precision Cancer Consortium’s (PCC) education and awareness workstream is to uncover the challenges faced by healthcare professionals (HCPs) when implementing Comprehensive Genomic Profiling (CGP).

June 2024, ASCO Annual Meeting, Chicago – The Precision Cancer Consortium (PCC), in partnership with Massive Bio, has unveiled compelling results from a comprehensive study conducted on a multi-sponsor pharmaceutical platform. This study rigorously tested...

The problem: Clinical research teams manually match patients one-trial-at-a-time, taking approximately 25 minutes per trial. This limits patients’ choices and clinical trial enrolment rates. The solution: In 2023 a collaborative project between PCC and...

The Precision Cancer Consortium (PCC) will foster collaboration to improve global patient access to comprehensive genomic testing.